REDEFINING NEURODEGENERATIVE MEDICINE Trademark
Trademark Overview
On Monday, July 7, 2025, a trademark application was filed for REDEFINING NEURODEGENERATIVE MEDICINE with the United States Patent and Trademark Office. The USPTO has given the REDEFINING NEURODEGENERATIVE MEDICINE trademark a serial number of 99269525. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, December 10, 2025. This trademark is owned by Repeat Therapeutics, Inc.. The REDEFINING NEURODEGENERATIVE MEDICINE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Providing medical and scientific research information in the field of pharmaceuticals; Providing a website featuring research information related to neuropathic pain, neurodegenerative diseases, neurological conditions, and degenerative brain diseases; Providing a website featuring medical research information related to neuropathic pain, neurodegenerative diseases, neurological conditions, and degenerative brain diseases; Research and development of pharmaceuticals; Research and development of technology in the field of pharmaceuticals; Pharmaceutical drug development services
General Information
| Serial Number | 99269525 |
| Word Mark | REDEFINING NEURODEGENERATIVE MEDICINE |
| Filing Date | Monday, July 7, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Wednesday, December 10, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 30, 2025 |
Trademark Statements
| Goods and Services | Providing medical and scientific research information in the field of pharmaceuticals; Providing a website featuring research information related to neuropathic pain, neurodegenerative diseases, neurological conditions, and degenerative brain diseases; Providing a website featuring medical research information related to neuropathic pain, neurodegenerative diseases, neurological conditions, and degenerative brain diseases; Research and development of pharmaceuticals; Research and development of technology in the field of pharmaceuticals; Pharmaceutical drug development services |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 7, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Repeat Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | La Jolla, CA 92037 |
Trademark Events
| Event Date | Event Description |
| Monday, July 7, 2025 | NEW APPLICATION ENTERED |
| Monday, July 7, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, November 11, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, November 24, 2025 | ASSIGNED TO EXAMINER |
| Friday, November 28, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, November 28, 2025 | NON-FINAL ACTION E-MAILED |
| Friday, November 28, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, December 3, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, December 3, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, December 3, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 4, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
